Follow-The-Filings

Security · featured owners

PLRX Pliant Therapeutics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.1%
  • $555K

Who owns this now

Largest portfolio weights among featured holders · max 0.1% (Nathan Fischel - Dafna Capital Management) · not free-float ownership

  1. Nathan Fischel 0.11%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Nathan Fischel - Dafna Capital Management 2026 Q2 0.11% Hold 487,000 $555K history

1 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 20 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 5.02 Filing Doc
8-K 8.01 Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,3.03,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 5.02 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02 Filing Doc
8-K 1.02 Filing Doc
8-K 9.01 Filing Doc
10-Q Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 5 rows shown

Filed Form Detail Links
4 Period Jul 9, 2026 · 2 forms Filing Doc
4 Period Jun 11, 2026 · 6 forms Filing Doc
4 Period Apr 17, 2026 · 4 forms Filing Doc
4 Period Jan 22, 2026 · 4 forms Filing Doc
4 Period Jan 20, 2026 · 4 forms Filing Doc

Updated about 16 hours ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $1.58M $0M $0M
Net income -$161.34M -$210.3M -$149.34M
Net margin * -10211.1% — —

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $505.5M $362.26M $196.45M
Total non-current assets * $6.65M $34.68M $28.78M
Total assets $512.15M $396.95M $225.23M
Total current liabilities $28.52M $33.22M $16.36M
Total non-current liabilities * $10.05M $59.65M $27.66M
Total equity $473.58M $304.08M $181.2M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$116.36M -$155.5M -$128.34M
Cash from investing -$127.01M $140.34M $134.29M
Cash from financing $274.4M $23.12M -$31.7M
Net change in cash $31.03M $7.95M -$25.74M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders